BD with pre-market approval from FDA for BD Onclarity HPV assay
BD has received pre-market approval from the U.S. Food and Drug Administration for the BD Onclarity HPV assay, the company…
Pharmaceuticals, Biotechnology and Life Sciences
BD has received pre-market approval from the U.S. Food and Drug Administration for the BD Onclarity HPV assay, the company…
The U.S. Food and Drug Administration said Thursday it has warned Becton Dickinson (BD) about several violations of federal law. BD…
BD has started an offer to repurchase all of its outstanding 3.000% Notes until May 15, 2026 that were issued…
BD has broken ground on a $60 million upgrade of its Columbus-East facility on Wednesday.
BD (Becton, Dickinson and Company), a medical technology company, has completed the acquisition of Israeli-based Caesarea Medical Electronics (CME), a global infusion pump systems manufacturer.
BD said on Wednesday that its BD Veritor System Flu A+B, a digital immunoassay for the rapid detection of influenza, meets the new Food and Drug Administration’s (FDA’s) performance requirements.
BD (Becton, Dickinson and Company) has launched its new BD Institute for Medication Management Excellence, developed to help advance the safe and efficient management of medication across the continuum of care.
BD (Becton, Dickinson) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of PleurX catheter system in certain problems like heart failure.
Becton, Dickinson’s (BD’s) new kits that provide an easier method to identify and quantify genetic information in individual cells for genomics-based research, have started selling.